Head and Neck Neuroendocrine Neoplasm — Trials

Head and Neck Neuroendocrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03838692	Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer	withdrawn	Phase 2	0	Antonio FojoOTHER	0	Oct 13, 2021	clinicaltrials
NCT04106843	Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers	withdrawn	Phase 2	0	M.D. Anderson Cancer CenterOTHER	1	Sep 7, 2020	clinicaltrials